Glomerular prostanoid production is modified by plasma samples of hypertensive and diabetic patients

Acta Physiol Hung. 1997;85(1):17-28.

Abstract

The autocrin-paracrin prostanoid system plays a major role in the enhancement or inhibition of renal tissue damage. Our hypothesis was that there might be circulating factors in the plasma with a capability to modify renal (glomerular) prostanoid synthesis. We measured the synthesis of prostacyclin 1-2 (PGI2) and thromboxan A-2 (TxA2) of isolated glomeruli, incubated in plasma samples obtained from hypertensive and diabetic (NIDDM) patients. It was found that these plasma samples decreased the renal PGI2/TxA2 ratio, mostly by decreasing glomerular PGI2 synthesis and, to a lesser extent, increasing the synthesis of TxA2. Our results demonstrate that circulating factors in hypertension and diabetes might play a role in renal damage seen in these conditions.

MeSH terms

  • Adult
  • Angiotensin II / pharmacology
  • Animals
  • Arginine Vasopressin / pharmacology
  • Bradykinin / pharmacology
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Nephropathies / etiology
  • Epoprostenol / biosynthesis
  • Female
  • Humans
  • Hypertension / blood*
  • Hypertension / complications
  • In Vitro Techniques
  • Kidney / injuries
  • Kidney Diseases / etiology
  • Kidney Glomerulus / drug effects
  • Kidney Glomerulus / metabolism*
  • Male
  • Middle Aged
  • Prostaglandins / biosynthesis*
  • Rats
  • Rats, Inbred WKY
  • Thromboxane A2 / biosynthesis

Substances

  • Prostaglandins
  • Angiotensin II
  • Arginine Vasopressin
  • Thromboxane A2
  • Epoprostenol
  • Bradykinin